Onboarding Patients on JAK Inhibitors for Atopic Dermatitis - Episode 4
Choosing Between Oral JAK Inhibitors in Atopic Dermatitis
Published on:
Ruth Ann Vleugels, MD, MPH, MBA, provides insights on factors that inform JAK inhibitor treatment selection for patients with atopic dermatitis.
Video content above is prompted by the following questions:
- How do you choose between different JAK inhibitors? What role do efficacy and safety data play in your selection?
- What are important considerations when choosing a JAK inhibitor in specific patient populations (e.g., older adults ≥65 yr)?
